TABLE 1

Demographic and Clinical Characteristics of Study Participants

CharacteristicOral Antimicrobial Agents (n = 123)OPAT (n = 89)P
Age, y, mean ± SD7.25 ± 4.928.38 ± 6.29.160
Boys, n (%)67 (54.5)54 (60.67).368
Race, n (%).097
 White104 (84.6)80 (89.9)
 Asian American0 (0.0)3 (3.37)
 African American5 (4.07)0 (0)
 American Indian2 (1.63)1 (1.12)
 Native Hawaiian or Pacific Islander9 (7.32)3 (3.37)
 Multiracial1 (0.81)1 (1.12)
 Unknown2 (1.63)1 (1.12)
Clinical indication, n (%)
 CNS infection4 (3.25)32 (36.0)<.001
 Endocarditis0 (0.00)5 (5.62).012
 Osteomyelitis and/or septic arthritis76 (61.8)23 (25.9)<.001
 Pneumonia23 (18.7)2 (2.25)<.001
 Intraabdominal infection5 (4.07)5 (5.62).597
 Musculoskeletal with hardware1 (0.81)13 (14.6)<.001
 Other14 (11.4)13 (14.6).487
Length of hospital stay, h, median (IQR)100 (68–252)159 (112–250)<.001
Duration of antimicrobial use, d, median (IQR)27.0 (21–45)39.0 (24–95).011
ICU admissions, n (%)18 (14.6)32 (36.0)<.001
Time from hospital discharge to survey, median (IQR)13.00 (10–20)15.0 (11–28).0504
  • IQR, interquartile range; —, not applicable.